Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI

被引:8
|
作者
Zhang, Yan-Nan [1 ]
Lu, Zhen-Guo [1 ]
Wang, Shuai-Dong [2 ]
Lu, Xin [1 ]
Zhu, Lei-Lei [1 ]
Yang, Xu [1 ]
Fu, Li-Ping [1 ]
Zhao, Jun [3 ]
Wang, Hai-Feng [2 ]
Xiang, Zuo-Lin [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Radiat Oncol, Shanghai 200120, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Urol, Shanghai 200120, Peoples R China
[3] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Nucl Med, Shanghai 200120, Peoples R China
基金
中国国家自然科学基金;
关键词
Prostate cancer; Gross tumor volume; Radiotherapy; PSMA PET; MRI; HYBRID PET/MRI; PET/CT; VALIDATION; PSMA; MRI; RECURRENCE; GUIDELINES; LESIONS;
D O I
10.1186/s40644-022-00475-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We aimed to assess the clinical value of F-18-PSMA-1007 and Ga-68-PSMA-11 PET/MRI in the gross tumor volume (GTV) delineation of radiotherapy for prostate cancer (PCa). Methods Sixty-nine patients were retrospectively enrolled (57 in the F-18 subgroup and 12 in the Ga-68 subgroup). Three physicians delineated the GTV and tumor length by the visual method and threshold method with thresholds of 30%, 40%, 50%, and 60% SUVmax. The volume correlation and differences in GTVs were assessed. The dice similarity coefficient (DSC) was applied to estimate the spatial overlap between GTVs. For 51 patients undergoing radical prostatectomy, the tumor length (Lpath) of the maximum area was measured, and compared with the longest tumor length obtained based on the images (L-MRI, L-PET/MRI, L-PET, L-PET30%, L-PET40%, L-PET50%, L-PET60%) to determine the best delineation method. Results In the F-18 subgroup, (1) GTV-PET/MRI (p < 0.001) was significantly different from the reference GTV-MRI. DSC between them was > 0.7. (2) GTV-MRI (R-2 = 0.462, p < 0.05) was the influencing factor of DSC. In the Ga-68 subgroup, (1) GTV-PET/MRI (p < 0.05) was significantly different from the reference GTV-MRI. DSC between them was > 0.7. (2) There was a significant correlation between GTV-MRI (r = 0.580, p < 0.05) and DSC. The longest tumor length measured by PET/MRI was in good agreement with that measured by histopathological analysis in both subgroups. Conclusion It is feasible to visually delineate GTV on PSMA PET/MRI in PCa radiotherapy, and we emphasize the utility of PET/MRI fusion images in GTV delineation. In addition, the overlap degree was the highest between GTV-MRI and GTV-PET/MRI, and it increased with increasing volume.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] 68Ga-PSMA-11 PET accuracy in recurrent prostate cancer
    Telo, Silvi
    Farolfi, Andrea
    Castellucci, Paolo
    Fanti, Stefano
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (06) : 772 - 774
  • [32] 68Ga-PSMA-11 PET/CT and PET/MRI in Rectal Linitis Plastica Secondary to Prostate Adenocarcinoma
    Zhao, Qian
    Dong, Hui
    Dong, Aisheng
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (03) : 282 - 285
  • [33] Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion
    Rahbar, Kambiz
    Weckesser, Matthias
    Ahmadzadehfar, Hojjat
    Schaefers, Michael
    Stegger, Lars
    Boegemann, Martin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (06) : 1076 - 1077
  • [34] Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion
    Kambiz Rahbar
    Matthias Weckesser
    Hojjat Ahmadzadehfar
    Michael Schäfers
    Lars Stegger
    Martin Bögemann
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1076 - 1077
  • [35] 68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer
    Sachpekidis, Christos
    Kopka, Klaus
    Eder, Matthias
    Hadaschik, Boris A.
    Freitag, Martin T.
    Pan, Leyun
    Haberkorn, Uwe
    Dimitrakopoulou-Strauss, Antonia
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (11) : E473 - E479
  • [36] 68Ga-PSMA-11 dynamic PET/CT in the diagnostics of primary prostate cancer
    Sachpekidis, C.
    Eder, M.
    Kopka, K.
    Mier, W.
    Hadaschik, B. A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S669 - S669
  • [37] Primary Staging of Prostate Cancer Patients with [18F]PSMA-1007 PET/CT Compared with [68Ga]Ga-PSMA-11 PET/CT
    Hoffmann, Manuela A.
    Mueller-Huebenthal, Jonas
    Rosar, Florian
    Fischer, Nicolas
    von Eyben, Finn Edler
    Buchholz, Hans-Georg
    Wieler, Helmut J.
    Schreckenberger, Mathias
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [38] PSMA-PI-RADS in 68Ga-PSMA-11 PET/MRI Improve the Differentiation of Naive Prostate Cancer and Primary Staging: Pilot Study
    Li, Xiaoyuan
    Ai, Shuyue
    Li, Rushuai
    Xie, Yan
    Qiu, Fan
    Wang, Feng
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] Diagnostic accuracy, concordance and certainty with 68Ga-PSMA-11 PET/MRI fusion compared to mpMRI and 68Ga-PSMA-11 PET/CT alone for prostate cancer diagnosis: A PRIMARY trial sub-study
    Doan, P. N.
    Counter, W.
    Sheehan-Dare, G.
    Papa, N.
    Ho, B.
    Lee, J.
    Liu, V
    Thompson, J.
    Agrawal, S.
    Roberts, M.
    Algharzo, O.
    Buteau, J.
    Hofman, M.
    Moon, D.
    Murphy, D.
    Stricker, P.
    Emmett, L.
    EUROPEAN UROLOGY, 2022, 81 : S1103 - S1104
  • [40] Utility of PSMA-PET derived volumetric parameters in initial risk stratification and prediction of prostate cancer metastasis - a head-to-head comparison of the radiotracers 18F-PSMA-1007 and 68Ga-PSMA-11
    Chandekar, Kunal Ramesh
    Satapathy, Swayamjeet
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    NUCLEAR MEDICINE COMMUNICATIONS, 2024, 45 (10) : 883 - 891